These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 7018865

  • 21. Bovine surfactant (surfactant TA) therapy in immature baboons with hyaline membrane disease.
    Vidyasagar D, Maeta H, Raju TN, John E, Bhat R, Go M, Dahiya U, Roberson Y, Yamin A, Narula A.
    Pediatrics; 1985 Jun; 75(6):1132-42. PubMed ID: 3846883
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Surfactant replacement therapy in utero for prevention of hyaline membrane disease in the preterm baboon.
    Galan HL, Cipriani C, Coalson JJ, Bean JD, Collier G, Kuehl TJ.
    Am J Obstet Gynecol; 1993 Oct; 169(4):817-24. PubMed ID: 8238135
    [Abstract] [Full Text] [Related]

  • 24. Asphyxia and hyaline membrane disease in neonatal monkeys.
    Hessler JR, Mantilla G, Kirkpatrick BV, Donnelly WH, Cassin S, Eitzman DV.
    Am J Perinatol; 1985 Apr; 2(2):101-7. PubMed ID: 3854275
    [Abstract] [Full Text] [Related]

  • 25. [Deficiency of surfactant in the newborn: pulmonary hyaline membrane disease].
    Salvioli GP.
    Torace; 1976 Jan; 18(1-2):3-12. PubMed ID: 1036633
    [No Abstract] [Full Text] [Related]

  • 26. Cellular and biochemical aspects of pulmonary surfactant in health and disease.
    Kikkawa Y, Smith F.
    Lab Invest; 1983 Aug; 49(2):122-39. PubMed ID: 6348405
    [No Abstract] [Full Text] [Related]

  • 27. Surfactant replacement therapy in newborns with hyaline membrane disease.
    Grobman DW, Foley MM.
    Crit Care Nurs Clin North Am; 1992 Sep; 4(3):515-20. PubMed ID: 1388997
    [Abstract] [Full Text] [Related]

  • 28. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease.
    Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW.
    Pediatrics; 1987 Jan; 79(1):31-7. PubMed ID: 3540835
    [Abstract] [Full Text] [Related]

  • 29. Pathogenesis of neonatal lung lesions induced by artificial ventilation: evidence against the role of barotrauma.
    Nilsson R, Grossmann G, Robertson B.
    Respiration; 1980 Jan; 40(4):218-25. PubMed ID: 6894337
    [Abstract] [Full Text] [Related]

  • 30. [Morphofunctional state of the APUD-system cells of the lungs in hyaline membrane disease of newborn infants].
    Bubnova NI.
    Arkh Patol; 1987 Jan; 49(8):47-52. PubMed ID: 2890337
    [Abstract] [Full Text] [Related]

  • 31. Treatment of hyaline membrane disease by human amniotic fluid surfactant.
    Jin HZ, Chen C, Jin QL, Shao XM.
    Chin Med J (Engl); 1989 Dec; 102(12):944-6. PubMed ID: 2517741
    [Abstract] [Full Text] [Related]

  • 32. Surfactant quantity and composition during recovery from hyaline membrane disease.
    Jackson JC, Palmer S, Truog WE, Standaert TA, Murphy JH, Hodson WA.
    Pediatr Res; 1986 Dec; 20(12):1243-7. PubMed ID: 3642428
    [Abstract] [Full Text] [Related]

  • 33. Surfactant replacement therapy.
    Kresch MJ, Lin WH, Thrall RS.
    Thorax; 1996 Nov; 51(11):1137-54. PubMed ID: 8958900
    [No Abstract] [Full Text] [Related]

  • 34. [Factors increasing susceptibility to neonatal hyaline membrane syndrome and its prevention. I. Deficiency of surfactant and glucocorticoid treatment].
    Uszyńska-Folejewska R, Uszyński M.
    Pediatr Pol; 1977 Dec; 52(12):1413-7. PubMed ID: 343058
    [No Abstract] [Full Text] [Related]

  • 35. High PEEP decreases hyaline membrane formation in surfactant deficient lungs.
    Argiras EP, Blakeley CR, Dunnill MS, Otremski S, Sykes MK.
    Br J Anaesth; 1987 Oct; 59(10):1278-85. PubMed ID: 3314957
    [Abstract] [Full Text] [Related]

  • 36. [Pulmonary hyaline membranes in adults. Oxygen toxicity].
    Hugues FC, Marsan C, Cornu P, Manicacci M, Caulin C, Segrestaa JM, Lamotte M.
    Sem Hop; 1973 Jan 08; 49(2):125-42. PubMed ID: 4119629
    [No Abstract] [Full Text] [Related]

  • 37. The prevention of hyaline membrane disease (HMD) in the preterm fetal lamb through the static inflation of the lungs: the conditioning of the fetal lungs.
    Kolobow T, Solca M, Presenti A, Buckhold D, Pierce JD.
    Trans Am Soc Artif Intern Organs; 1980 Jan 08; 26():567-72. PubMed ID: 6910328
    [Abstract] [Full Text] [Related]

  • 38. [High frequency oscillation ventilation after surfactant use in hyaline membrane disease. Outcome of ventilation parameters].
    Claris O, Lapillonne A, Madinier-Chappat N, Miguet D, Salle BL.
    Cah Anesthesiol; 1994 Jan 08; 42(3):325-8. PubMed ID: 7812856
    [Abstract] [Full Text] [Related]

  • 39. The late administration of surfactant.
    Ballot DE, Rothberg AD, Davies VA.
    S Afr Med J; 1995 Jul 08; 85(7):644-6. PubMed ID: 7482080
    [Abstract] [Full Text] [Related]

  • 40. The prevention of hyaline membrane disease: new concepts and approaches to therapy.
    Farrell PM, Kotas RV.
    Adv Pediatr; 1976 Jul 08; 23():213-69. PubMed ID: 795280
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.